Common Contracts

52 similar null contracts by Seelos Therapeutics, Inc., Algernon Pharmaceuticals Inc., Amphitrite Digital Inc, others

SHARES OF COMMON STOCK OF AMPHITRITE DIGITAL INCORPORATED UNDERWRITING AGREEMENT
Amphitrite Digital Inc • January 31st, 2024 • Water transportation • New York

The undersigned, Amphitrite Digital Incorporated, a company incorporated under the laws of the United States Virgin Islands (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries or affiliates of Amphitrite Digital Incorporated, the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Kingswood Investments is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.

AutoNDA by SimpleDocs
SHARES OF COMMON STOCK OF AMPHITRITE DIGITAL INCORPORATED UNDERWRITING AGREEMENT
Amphitrite Digital Inc • January 23rd, 2024 • Water transportation • New York

The undersigned, Amphitrite Digital Incorporated, a company incorporated under the laws of the United States Virgin Islands (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries or affiliates of Amphitrite Digital Incorporated, the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Kingswood Investments is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.

UNDERWRITING AGREEMENT
Dolphin Entertainment, Inc. • November 2nd, 2023 • Services-personal services • New York

The undersigned, Dolphin Entertainment, Inc., a company incorporated under the laws of Florida (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries or affiliates of Dolphin Entertainment, Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Maxim Group LLC is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.

9,018,519 SHARES OF COMMON STOCK 22,222,222 COMMON WARRANTS (EXERCISABLE FOR 22,222,222 WARRANT SHARES) AND 2,092,592 PRE-FUNDED WARRANTS (EXERCISABLE FOR 2,092,592 WARRANT SHARES) T2 BIOSYSTEMS, INC. UNDERWRITING AGREEMENT
T2 Biosystems, Inc. • February 16th, 2023 • Surgical & medical instruments & apparatus • New York

The undersigned, T2 Biosystems, Inc., a company incorporated under the laws of Delaware (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries or affiliates of T2 Biosystems, Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Craig-Hallum Capital Group LLC is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.

UNDERWRITING AGREEMENT
SHENGFENG DEVELOPMENT LTD • January 26th, 2023 • Trucking & courier services (no air) • New York
SHARES OF COMMON STOCK AND WARRANTS OF QUANERGY SYSTEMS, INC. UNDERWRITING AGREEMENT
Quanergy Systems, Inc. • October 24th, 2022 • Motor vehicle parts & accessories • New York

The undersigned, Quanergy Systems, Inc. a company incorporated under the laws of Delaware (the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Maxim Group LLC is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.

COMMON WARRANTS OF ALGERNON PHARMACEUTICALS INC. UNDERWRITING AGREEMENT
Algernon Pharmaceuticals Inc. • June 3rd, 2022 • Pharmaceutical preparations • New York

The undersigned, Algernon Pharmaceuticals Inc., a company existing under the laws of the Province of British Columbia, Canada (collectively with its subsidiaries, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries of Algernon Pharmaceuticals Inc., the "Company"), hereby confirms its agreement (this "Agreement") with the several underwriters (such underwriters, including the Representative (as defined below), the "Underwriters" and each an "Underwriter") named in Schedule I hereto for which Ladenburg Thalmann & Co. Inc. is acting as representative to the several Underwriters (the "Representative" and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.

COMMON WARRANTS OF ALGERNON PHARMACEUTICALS INC. UNDERWRITING AGREEMENT
Algernon Pharmaceuticals Inc. • April 25th, 2022 • Pharmaceutical preparations • New York

The undersigned, Algernon Pharmaceuticals Inc., a company existing under the laws of the Province of British Columbia, Canada (collectively with its subsidiaries, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries of Algernon Pharmaceuticals Inc., the "Company"), hereby confirms its agreement (this "Agreement") with the several underwriters (such underwriters, including the Representative (as defined below), the "Underwriters" and each an "Underwriter") named in Schedule I hereto for which Ladenburg Thalmann & Co. Inc. is acting as representative to the several Underwriters (the "Representative" and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.

1,650,000 SHARES OF COMMON STOCK CONCIERGE TECHNOLOGIES, INC. UNDERWRITING AGREEMENT
Marygold Companies, Inc. • March 15th, 2022 • Finance services • New York

The undersigned, CONCIERGE TECHNOLOGIES, INC., a company incorporated under the laws of Nevada (collectively with its subsidiaries, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries of CONCIERGE TECHNOLOGIES, INC., the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which MAXIM GROUP LLC (“Maxim”) is acting as representative to the several Underwriters (in such capacity, the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.

RA MEDICAL SYSTEMS, INC. UNDERWRITING AGREEMENT
Ra Medical Systems, Inc. • February 9th, 2022 • Surgical & medical instruments & apparatus • New York

The undersigned, Ra Medical Systems, Inc., a Delaware corporation (the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters, if any (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Ladenburg Thalmann & Co. Inc. is acting as representative (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.

SHARES OF COMMON STOCK CONCIERGE TECHNOLOGIES, INC. UNDERWRITING AGREEMENT
Concierge Technologies Inc • January 31st, 2022 • Finance services • New York

The undersigned, CONCIERGE TECHNOLOGIES, INC., a company incorporated under the laws of Nevada (collectively with its subsidiaries, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries of CONCIERGE TECHNOLOGIES, INC., the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which MAXIM GROUP LLC (“Maxim”) is acting as representative to the several Underwriters (in such capacity, the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.

SHARES OF OF APPLIED UV, INC. UNDERWRITING AGREEMENT
Applied UV, Inc. • December 13th, 2021 • Electric lighting & wiring equipment • New York

The undersigned, Applied UV, Inc., a company incorporated under the laws of Delaware (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries or affiliates of Applied UV, Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which EF Hutton, division of Benchmark Investments, LLC. is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.

UNDERWRITING AGREEMENT
Nexgel, Inc. • December 10th, 2021 • Surgical & medical instruments & apparatus • New York

The undersigned, NexGel, Inc., a company incorporated under the laws of Delaware (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries or affiliates of NexGel, Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Maxim Group LLC is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.

UNDERWRITING AGREEMENT
NeuroSense Therapeutics Ltd. • November 19th, 2021 • Pharmaceutical preparations • New York

The undersigned, NeuroSense Therapeutics Ltd., a company incorporated under the laws of Israel (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries or affiliates of NeuroSense Therapeutics Ltd., the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Maxim Group LLC is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.

ADVANCED HUMAN IMAGING LTD. UNDERWRITING AGREEMENT
Advanced Human Imaging LTD • November 10th, 2021 • Services-prepackaged software • New York

The undersigned, Advanced Human Imaging Ltd., a company incorporated under the laws of Australia with Australian Company Number 602 111 115 (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement (as defined below) as being subsidiaries or affiliates of Advanced Human Imaging Ltd., the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Maxim Group LLC is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein. The Underlying Ordinary Share

2,300,000 SHARESOF COMMON STOCK AND 2,300,000 WARRANTS OF BIORESTORATIVE THERAPIES, INC. AMENDED AND RESTATED UNDERWRITING AGREEMENT
BioRestorative Therapies, Inc. • November 8th, 2021 • Services-misc health & allied services, nec • New York

The undersigned, BioRestorative Therapies, Inc., a company incorporated under the laws of Delaware (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries or affiliates of BioRestorative Therapies, Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Roth Capital Partners, LLC is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein. This Amended and Restated Underwriting Agreement amends, restates and super

UNDERWRITING AGREEMENT
Mawson Infrastructure Group Inc. • October 1st, 2021 • Services-computer processing & data preparation • New York

The undersigned, Mawson Infrastructure Group, Inc., a company incorporated under the laws of Delaware (collectively with its subsidiaries, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries of Mawson Infrastructure Group, Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which H.C. Wainwright & Co., LLC is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.

UNDERWRITING AGREEMENT
Applied UV, Inc. • June 25th, 2021 • Electric lighting & wiring equipment • New York

The undersigned, Applied UV, Inc., a company incorporated under the laws of Delaware (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries or affiliates of Applied UV, Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Ladenburg Thalmann & Co. Inc. is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.

3,230,000 SHARES OF COMMON STOCK OF MONAKER GROUP, INC. UNDERWRITING AGREEMENT
Monaker Group, Inc. • May 18th, 2021 • Transportation services • New York

The undersigned, Monaker Group, Inc., a company incorporated under the laws of Nevada (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries or affiliates of Monaker Group, Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Kingswood Capital Markets, division of Benchmark Investments, Inc. is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.

21,639,851 SHARES of Common Stock
ASTROTECH Corp • April 12th, 2021 • Laboratory analytical instruments • New York
UNDERWRITING AGREEMENT
Cyclacel Pharmaceuticals, Inc. • March 15th, 2021 • Pharmaceutical preparations • New York

The undersigned, Cyclacel Pharmaceuticals, Inc., a Delaware corporation (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries or affiliates of Cyclacel Pharmaceuticals, Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Oppenheimer & Co. Inc. is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.

AutoNDA by SimpleDocs
UNDERWRITING AGREEMENT
GLORY STAR NEW MEDIA GROUP HOLDINGS LTD • February 23rd, 2021 • Services-computer processing & data preparation • New York

The undersigned, Glory Star New Media Group Holdings Limited, a Cayman Islands exempted company (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries or affiliates of Glory Star New Media Group Holdings Limited, the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Univest Securities, LLC is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.

UNDERWRITING AGREEMENT
iMedia Brands, Inc. • February 18th, 2021 • Retail-catalog & mail-order houses • New York

The undersigned, iMedia Brands, Inc., a company incorporated under the laws of Minnesota (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries or affiliates of iMedia Brands, Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Craig-Hallum Capital Group LLC is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.

29,268,294 SHARES of Common Stock DIFFUSION PHARMACEUTICALS INC. AMENDED AND RESTATED UNDERWRITING AGREEMENT
Diffusion Pharmaceuticals Inc. • February 18th, 2021 • Pharmaceutical preparations • New York

The undersigned, Diffusion Pharmaceuticals Inc., a company incorporated under the laws of Delaware (collectively with its subsidiaries, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries of Diffusion Pharmaceuticals Inc., (the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which H.C. Wainwright & Co., LLC is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein. This Amended and Restated Underwriting Agreement amends, restates and supersedes in its entirety the pr

UNDERWRITING AGREEMENT
Monaker Group, Inc. • December 31st, 2020 • Transportation services • New York

The undersigned, Monaker Group, Inc., a company incorporated under the laws of Nevada (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries or affiliates of Monaker Group, Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representatives (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Kingswood Capital Markets, division of Benchmark Investments, Inc. and Aegis Capital Corp. are acting collectively as representative to the several Underwriters (the “Representatives” and each a “Representative” and if there are no Underwriters other than the Representatives, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set fort

CYCLO THERAPEUTICS, INC. UNDERWRITING AGREEMENT
Cyclo Therapeutics, Inc. • November 16th, 2020 • Industrial organic chemicals • New York

The undersigned, Cyclo Therapeutics, Inc., a company incorporated under the laws of Nevada (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries or affiliates of Cyclo Therapeutics, Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Maxim Group LLC is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.

UNDERWRITING AGREEMENT
Cleanspark, Inc. • October 9th, 2020 • Services-computer integrated systems design • New York

The undersigned, CleanSpark, Inc., a company incorporated under the laws of Nevada (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries or affiliates of CleanSpark, Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which H.C. Wainwright & Co., LLC is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.

UNDERWRITING AGREEMENT
Biohitech Global, Inc. • July 30th, 2020 • Services-educational services • New York

The undersigned, BioHiTech Global, Inc., a company incorporated under the laws of Delaware (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries or affiliates of BioHiTech Global, Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Maxim Group LLC is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.

EX-1 2 ex1_1.htm FORM OF UNDERWRITING AGREEMENT [ ] UNITS, CONSISTING OF [ ] SHARES of Common Stock and [ ] Warrants of ENVISION SOLAR INTERNATIONAL, INC. UNDERWRITING AGREEMENT November [ ], 2018 MAXIM GROUP LLC 405 Lexington Avenue New York, NY...
New York • May 5th, 2020

The undersigned, Envision Solar International, Inc., a company incorporated under the laws of the State of Nevada (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries or affiliates of Envision Solar International, Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Maxim Group LLC is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.

EX-1.1 2 a18-12086_1ex1d1.htm EX-1.1 SHARES OF COMMON STOCK, SERIES B WARRANTS (EXERCISABLE FOR SHARES) AND SERIES A WARRANTS (EXERCISABLE FOR SHARES) OF INVIVO THERAPEUTICS HOLDINGS CORP. FORM OF UNDERWRITING AGREEMENT Ladenburg Thalmann & Co. Inc....
New York • May 5th, 2020

The undersigned, InVivo Therapeutics Holdings Corp., a company incorporated under the laws of Nevada (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries or affiliates of InVivo Therapeutics Holdings Corp., the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Ladenburg Thalmann & Co. Inc. is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.

7,500,000 SHARES OF COMMON STOCK OF SEELOS THERAPEUTICS, INC. UNDERWRITING AGREEMENT
Seelos Therapeutics, Inc. • March 12th, 2020 • Pharmaceutical preparations • New York

The Benchmark Company, LLC As the Representative of the Several underwriters, if any, named in Schedule I hereto c/o The Benchmark Company, LLC 150 East 58th Street, 17th Floor New York, New York 10155

6,666,667 SHARES OF COMMON STOCK OF SEELOS THERAPEUTICS, INC. UNDERWRITING AGREEMENT
Seelos Therapeutics, Inc. • February 11th, 2020 • Pharmaceutical preparations • New York

The Benchmark Company, LLC As the Representative of the Several underwriters, if any, named in Schedule I hereto c/o The Benchmark Company, LLC 150 East 58th Street, 17th Floor New York, New York 10155

SHARES OF COMMON STOCK OF SEELOS THERAPEUTICS, INC. UNDERWRITING AGREEMENT
Seelos Therapeutics, Inc. • January 30th, 2020 • Pharmaceutical preparations • New York

The Benchmark Company, LLC As the Representative of the Several underwriters, if any, named in Schedule I hereto c/o The Benchmark Company, LLC 150 East 58th Street, 17th Floor New York, New York 10155

BIOCEPT, INC. UNDERWRITING AGREEMENT
Biocept Inc • November 15th, 2019 • Services-medical laboratories • New York
Time is Money Join Law Insider Premium to draft better contracts faster.